Vitamin D metabolites and risk of first clinical diagnosis of central nervous system demyelination

Authors :: Courtney Tiller
Lucinda J. Black
Anne-Louise Ponsonby
Bruce Taylor
Ingrid van der Mei
Michael W. Clarke
Robyn M. Lucas
Source :: The Journal of Steroid Biochemistry and Molecular Biology. 218:106060
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.
Abstract: Low 25-hydroxyvitamin D (25(OH)D) concentration is a recognised risk factor for multiple sclerosis (MS). Associations with vitamin D metabolites and vitamin D binding globulin (VDBG) have not been widely studied. We assessed the association between vitamin D metabolites (25(OH)D

Subjects :: Central Nervous System
24,25-Dihydroxyvitamin D 3
Vitamin D-Binding Protein
Endocrinology, Diabetes and Metabolism
Clinical Biochemistry
Australia
Cell Biology
Biochemistry
Endocrinology
Tandem Mass Spectrometry
Case-Control Studies
Ergocalciferols
Humans
Molecular Medicine
Vitamin D
Molecular Biology
Demyelinating Diseases

Tools